NL-OMON40539撤回3 期
Multicentre, Open-Label Trial to Assess the Safety and Tolerability of LF111 (Drospirenone 4.0 mg) Over 6 Cycles in Female Adolescents, With a 7-Cycle Extension Phase - CF111/304
aboratorios León Farma S.A0 个研究点目标入组 20 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 撤回
- 发起方
- 入组人数
- 20
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 12 至 17（—）
入选标准
- •Female adolescents aged 12-17 years and postmenarcheal for at least six months
排除标准
- •Known contraindication or hypersensitivity to ingredients or excipients of IMP
研究者
相似试验
进行中（未招募）
1 期
A clinical study for testing safety and tolerability of 4.0 mg Drospirenone (LF111) during 6 cycles at several study sites with the possibility of a trial extension for further 7 cyclesEUCTR2013-005234-37-FIaboratorios León Farma S.A.130
进行中（未招募）
1 期
A clinical study for testing safety and tolerability of 4.0 mg Drospirenone (LF111) during 6 cycles at several study sites with the possibility of a trial extension for further 7 cyclesOral contraception for postmenarcheal female adolescents, with or without intact hymen, aged 15-17 and without uncontrolled concomitant disease.MedDRA version: 17.0Level: PTClassification code 10030970Term: Oral contraceptionSystem Organ Class: 10042613 - Surgical and medical proceduresEUCTR2013-005234-37-SEaboratorios León Farma S.A.130
进行中（未招募）
1 期
A clinical study for testing safety and tolerability of 4.0 mg Drospirenone (LF111) during 6 cycles at several study sites with the possibility of a trial extension for further 7 cyclesEUCTR2013-005234-37-DEaboratorios León Farma S.A.130
进行中（未招募）
不适用
A clinical study for testing safety and tolerability of 4.0 mg Drospirenone (LF111) during 6 cycles at several study sites with the possibility of a trial extension for further 7 cyclesEUCTR2013-005234-37-NLaboratorios León Farma S.A.130
进行中（未招募）
1 期
Open-label, Multicenter Trial of M1774 (DDRiver Solid Tumors 301)JPRN-jRCT2031220326Yamaki Masataka17